Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹279 Cr
up ₹15 Cr vs Mar 2024
- Stocks held
- 19
- unchanged
- Top 10 weight
- 71.6%
- of the portfolio in its ten largest
- Cash & debt
- 1.1%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 4
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In April 2024 it disclosed 19 stocks worth ₹279 Cr, up ₹15 Cr from Mar 2024. Its largest positions were Reliance Industries Limited (9.4%), Aurobindo Pharma Limited (9.2%), Poly Medicure Limited (8.8%); the ten largest together made up 71.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 47.8% of its equity. Cash and debt stood at 1.1%. Compared with Mar 2024 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
5%
Holds more stocks than 5% of peers
Cash
12%
Holds more cash than 12% of peers
What these mean: concentration · cash
Holdings in April 2024
Download CSVEvery line the fund disclosed, with the change against Mar 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Reliance Industries Limited | 9.38% | down 0.66 pts | ₹26.2 Cr | down ₹34 L | Trimmed |
| Aurobindo Pharma Limited | 9.22% | up 0.03 pts | ₹25.8 Cr | up ₹1.4 Cr | Added |
| Poly Medicure Limited | 8.75% | down 0.19 pts | ₹24.5 Cr | up ₹80 L | Added |
| Life Insurance Corporation Of India | 8.58% | up 0.09 pts | ₹24 Cr | up ₹1.5 Cr | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 7.91% | up 4.53 pts | ₹22.1 Cr | up ₹13.2 Cr | Added |
| Indraprastha Medical Corporation Limited | 6.41% | up 6.41 pts | ₹17.9 Cr | up ₹17.9 Cr | New |
| Jubilant Pharmova Limited | 6.03% | up 0.64 pts | ₹16.9 Cr | up ₹2.6 Cr | Added |
| Kovai Medical Center and Hospital Limited | 5.90% | up 0.33 pts | ₹16.5 Cr | up ₹1.7 Cr | Added |
| Gujarat Themis Biosyn Ltd | 4.77% | down 0.09 pts | ₹13.3 Cr | up ₹47 L | Added |
| Dishman Carbogen Amcis Limited | 4.65% | down 0.34 pts | ₹13 Cr | down ₹19 L | Trimmed |
| SMS Pharmaceuticals Limited | 4.40% | up 0.34 pts | ₹12.3 Cr | up ₹1.6 Cr | Added |
| Sequent Scientific Limited | 4.29% | up 0.06 pts | ₹12 Cr | up ₹79 L | Added |
| Indoco Remedies Limited | 3.75% | down 0.23 pts | ₹10.5 Cr | down ₹5 L | Trimmed |
| Suven Life Sciences Limited | 3.28% | up 0.14 pts | ₹9.2 Cr | up ₹87 L | Added |
| Granules India Limited | 3.18% | down 0.23 pts | ₹8.9 Cr | down ₹14 L | Trimmed |
| Aarti Pharmalabs Limited | 2.95% | up 0.31 pts | ₹8.3 Cr | up ₹1.3 Cr | Added |
| AstraZeneca Pharma India Limited | 2.22% | down 0.12 pts | ₹6.2 Cr | up ₹1 L | Held |
| BROOKS Laboratories Limited | 1.81% | up 0.10 pts | ₹5.1 Cr | up ₹54 L | Added |
| 91 Days Treasury Bill 02-May-2024 Debt | 1.79% | down 0.09 pts | ₹5 Cr | up ₹3 L | Added |
| Kopran Limited | 1.40% | down 0.06 pts | ₹3.9 Cr | up ₹4 L | Added |
| Cash, TREPS & receivables | −0.69% | up 0.72 pts | −₹1.9 Cr | up ₹1.8 Cr | Added |
What changed, Mar 2024 to Apr 2024
New New positions (1)
- Indraprastha Medical Corporation Limited6.4% · ₹17.9 Cr
Exited Exited (1)
- Metropolis Healthcare Limitedwas 5.5% · ₹14.7 Cr
Added Biggest additions
- GlaxoSmithKline Pharmaceuticals Limitedup ₹13.2 Cr (+4.53% pts)
- Jubilant Pharmova Limitedup ₹2.6 Cr (+0.64% pts)
- Kovai Medical Center and Hospital Limitedup ₹1.7 Cr (+0.33% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2024, the weight rose most in Pharmaceuticals & Biotechnology (+3.1 pts) and Healthcare Services (+0.5 pts), and fell most in Petroleum Products (−1.3 pts) and Pharmaceuticals (−1.1 pts).
- Pharmaceuticals & Biotechnology44.7% → 47.8%+3.1 pts
- Healthcare Services15.5% → 16.1%+0.5 pts
- Petroleum Products10.9% → 9.7%−1.3 pts
- Pharmaceuticals9.8% → 8.7%−1.1 pts
- Healthcare Equipment & Supplies9.8% → 9.0%−0.7 pts
- Insurance9.3% → 8.8%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2023 | Jan 2024 | Mar 2024 | Apr 2024 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 55.2% | 58.1% | 44.7% | 47.8% |
| Healthcare Services | 11.8% | 5.2% | 15.5% | 16.1% |
| Petroleum Products | 13.2% | 13.4% | 10.9% | 9.7% |
| Healthcare Equipment & Supplies | 11.5% | 2.9% | 9.8% | 9.0% |
| Insurance | — | 13.4% | 9.3% | 8.8% |
| Pharmaceuticals | 8.3% | 6.9% | 9.8% | 8.7% |
Allocation in Apr 2024change vs Mar 2024
- Pharmaceuticals & Biotechnology (10)47.8%▲ 3.1 pts
- Healthcare Services (3)16.1%▲ 0.5 pts
- Petroleum Products (1)9.7%▼ 1.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2024
1.1%
▲ 0.6 pts vs Mar 2024
- Cash alone
- −0.7%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.5% – 7.5%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.